Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILOR-DAPT Trial
KCT0008489Phase 4Recruiting
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in coronary arteriosclerosis, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Aug 2023; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0008489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008489.